Skip to main content

Want a detailed portfolio tracker?

Klotho Neurosciences Inc Com (KLTO) P/E (2024 - 2026)

Klotho Neurosciences Inc Com (KLTO) P/E from Sep 17, 2024 to Jul 8, 2026. The TTM Klotho Neurosciences Inc Com (KLTO) P/E is -2.07. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Klotho Neurosciences Inc Com (KLTO)

YearP/EChange
2026-2.07+52.75%
2025-1.36+42.91%
2024-0.95N/A

Comparison Klotho Neurosciences Inc Com (KLTO) P/E with competitors

Klotho Neurosciences Inc Com (KLTO) P/E is -2.07.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.61%
FGENFibroGen Inc0.24-111.59%
CHRSCoherus Biosciences Inc0.85-140.98%
FBIOFortress Biotech Inc0.95-145.83%
ORMPOramed Pharmaceuticals Inc1.50-172.58%
AGENAgenus Inc3.01-245.33%
INVAInnoviva Inc3.15-252.31%
VXRTVaxart Inc3.55-271.42%
CRMDCorMedix Inc3.63-275.22%
CVACCureVac N.V.4.45-314.68%
GLPGGalapagos NV4.86-334.64%
SRPTSarepta Therapeutics Inc4.88-335.76%
ABEOAbeona Therapeutics Inc5.39-360.16%
ABUSArbutus Biopharma Corp5.60-370.21%
ZVRAZevra Therapeutics Inc5.89-384.29%
SPROSpero Therapeutics Inc6.23-400.77%
CGENCompugen Ltd6.31-404.90%
RIGLRigel Pharmaceuticals6.87-431.85%
SLXNSilexion Therapeutics Corp7.30-452.33%
OMEROmeros Corporation9.26-547.11%
AUPHAurinia Pharmaceuticals Inc9.58-562.86%
PLXProtalix BioTherapeutics Inc10.89-625.93%
ACADAcadia Pharmaceuticals Inc11.73-666.37%
TBPHTheravance Biopharma Inc12.26-692.14%
ADMAAdma Biologics Inc12.42-699.67%
HRMYHarmony Biosciences Holdings Inc13.82-767.38%
SABSSAB Biotherapeutics Inc14.14-782.64%
NAGENiagen Bioscience Inc14.82-815.57%
INCYIncyte Corp15.82-864.07%
REGNRegeneron Pharmaceuticals Inc15.86-865.72%
PBYIPuma Biotechnology Inc17.32-936.18%
CPRXCatalyst Pharmaceuticals Inc17.44-942.15%
EXELExelixis Inc17.54-946.91%
TGTXTG Therapeutics Inc18.97-1015.87%
MDXGMimedx Group Inc20.55-1092.48%
XOMAXOMA Royalty Corp22.87-1204.65%
ARGXArgen X SE24.30-1273.39%
CTMXCytomX Therapeutics Inc24.82-1298.65%
XOMAOXOMA Royalty Corp25.34-1323.94%
HALOHalozyme Therapeutics Inc25.62-1337.41%
XOMAPXOMA Royalty Corp25.67-1339.65%
VRTXVertex Pharmaceuticals Inc27.99-1451.91%
RPRXRoyalty Pharma plc - Class A28.69-1485.36%
SLNOSoleno Therapeutics Inc29.02-1501.19%
ASNDAscendis Pharma A/S30.09-1552.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1930.83%
APLSApellis Pharmaceuticals Inc39.02-1984.39%
BMRNBiomarin Pharmaceutical Inc42.21-2138.47%
KRYSKrystal Biotech Inc45.34-2289.70%
ONCBeiGene Ltd69.54-3458.21%
PHARPharming Group N.V.75.03-3723.10%
TECHBio-Techne Corp101.96-5023.72%
VCELVericel Corp109.92-5408.26%
ALNYAlnylam Pharmaceuticals Inc117.96-5796.71%
GMABGenmab140.29-6874.85%
TLXTelix Pharmaceuticals Ltd162.15-7930.60%
CORTCorcept Therapeutics Inc212.86-10379.20%